Noninvasix Overview

  • Year Founded
  • 2007

Year Founded

  • Status
  • Private

  • Employees
  • 3

Employees

  • Latest Deal Type
  • Series A

  • Investors
  • 15

Noninvasix General Information

Description

Developer of an optoacoustic platform technology designed to non-invasively and continuously measure central venous saturation. The company's technology specializes in monitoring the severity of sepsis and septic shock non-invasively to diagnose and monitor the response to treatment of tissue hypoxia in real-time, enabling clinicians to more quickly and accurately diagnose critically ill patients and tailor treatments to improve outcomes.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Monitoring Equipment
Other Industries
Other Healthcare Technology Systems
Corporate Office
  • 301 University Boulevard
  • Galveston, TX 77555
  • United States
+1 (409) 000-0000

Noninvasix Timeline

2021202220232024
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Noninvasix Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
13. Later Stage VC (Series A) 24-Apr-2023 00.000 Completed Pre-Clinical Trials
12. Later Stage VC 06-May-2022 00.00 00.000 Completed Pre-Clinical Trials
11. Seed Round 18-Feb-2021 000 00.000 Completed Product Development
10. Seed Round 10-Jun-2020 00.000 00.000 0000 Completed Product Development
9. Angel (individual) 07-Jan-2019 Completed Startup
8. Grant 05-Aug-2018 00000 Completed Startup
7. Accelerator/Incubator 30-Nov-2016 Completed Startup
6. Seed Round 30-Dec-2015 Completed Startup
5. Accelerator/Incubator 05-Sep-2015 Completed Startup
4. Grant 03-Jun-2015 $5.8M Completed Startup
To view Noninvasix’s complete valuation and funding history, request access »

Noninvasix Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed 3 000,000 00.000000 00.0 00.0 00.0 0.000
Seed 2 000,000 00.000000 00.00 00.00 00 00.00 0.000
Seed 1 332,618 $0.001000 $1.02 $1.02 1x $1.02 3.4%
Seed 1,716,051 $0.001000 $1.22 $1.22 1x $1.22 17.53%
To view Noninvasix’s complete cap table history, request access »

Noninvasix Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of an optoacoustic platform technology designed to non-invasively and continuously measure central venous satu
Monitoring Equipment
Galveston, TX
3 As of 2024
00.000
00000000000 00.000

000 00

x ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate veli
0000000000 000000000
San Clemente, CA
00000 As of 0000
00.000
000000000 00.000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Noninvasix Competitors (1)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
ICU Medical Corporation San Clemente, CA 00000 00.000 000000000 00.000
You’re viewing 1 of 1 competitors. Get the full list »

Noninvasix Executive Team (4)

Name Title Board Seat Contact Info
David Giarracco Chief Executive Officer & Board Member
Graham Randall Ph.D Chief Science Officer
Donald Prough MD Co-Founder, Clinical Vice President & Board Member
You’re viewing 3 of 4 executive team members. Get the full list »

Noninvasix Board Members (9)

Name Representing Role Since
Daniel Parsley Green Park & Golf Ventures Board Observer 000 0000
David Giarracco Noninvasix Chief Executive Officer & Board Member 000 0000
Donald Prough MD Noninvasix Co-Founder, Clinical Vice President & Board Member 000 0000
James Helliwell MD Self Board Member 000 0000
Karerina Katerina Fialkovskaya Philips Board Observer 000 0000
You’re viewing 5 of 9 board members. Get the full list »

Noninvasix Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Noninvasix Investors (15)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Rockies Venture Club Angel Group Minority 000 0000 000000 0
Philips Corporation Minority 000 0000 000000 0
Green Park & Golf Ventures Venture Capital Minority 000 0000 000000 0
Philips North America Pension Plan Limited Partner Minority 000 0000 000000 0
Texas Ventures Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 15 investors. Get the full list »

Noninvasix FAQs

  • When was Noninvasix founded?

    Noninvasix was founded in 2007.

  • Who is the founder of Noninvasix?

    Rinat Esenaliev Ph.D and Donald Prough MD are the founders of Noninvasix.

  • Who is the CEO of Noninvasix?

    David Giarracco is the CEO of Noninvasix.

  • Where is Noninvasix headquartered?

    Noninvasix is headquartered in Galveston, TX.

  • What is the size of Noninvasix?

    Noninvasix has 3 total employees.

  • What industry is Noninvasix in?

    Noninvasix’s primary industry is Monitoring Equipment.

  • Is Noninvasix a private or public company?

    Noninvasix is a Private company.

  • What is Noninvasix’s current revenue?

    The current revenue for Noninvasix is 000000.

  • How much funding has Noninvasix raised over time?

    Noninvasix has raised $8.05M.

  • Who are Noninvasix’s investors?

    Rockies Venture Club, Philips, Green Park & Golf Ventures, Philips North America Pension Plan, and Texas Ventures are 5 of 15 investors who have invested in Noninvasix.

  • Who are Noninvasix’s competitors?

    ICU Medical is a competitor of Noninvasix.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »